Key result
Type 2 diabetic (db/db) mice exhibited increased ventricular arrhythmia susceptibility due to cardiac sympathetic dysfunction, which was completely inhibited by sympathetic blockade with propranolol.
Why the study?
Patients with T2DM face a greater risk of life-threatening cardiac arrhythmias, but the underlying mechanisms and potential influence of diabetic autonomic neuropathy remain poorly understood.
Increased ventricular arrhythmia susceptibility in type 2 diabetic mice is driven by cardiac sympathetic dysfunction, which can be inhibited by beta-blockade.
No takes yet. Share an insight, caveat, or question.
Does not support clinical beta-blockade for diabetic arrhythmia; hypothesis-generating for sympathetic mechanisms in human type 2 diabetes.
Jungen et al. (2019) studied Type 2 diabetes mellitus. Type 2 diabetes (db/db model) vs. Control mice was evaluated on Ventricular arrhythmia susceptibility and sympathetic dysregulation. Type 2 diabetic (db/db) mice exhibited increased ventricular arrhythmia susceptibility due to cardiac sympathetic dysfunction, which was completely inhibited by sympathetic blockade with propranolol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: